Cargando…

Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study

BACKGROUND: Pneumococcal polysaccharide vaccine (PPV) is recommended for all adults 65 years of age and older and for younger adults with high-risk conditions. While data from national surveys provide information on the proportion of adults 65 years of age and older reporting ever receipt of PPV the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jackson, Lisa A, Baxter, Roger, Naleway, Allison L, Belongia, Edward A, Baggs, James
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670847/ https://www.ncbi.nlm.nih.gov/pubmed/19321001 http://dx.doi.org/10.1186/1471-2334-9-37

Ejemplares similares

Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
por: Jackson, Lisa A, et al.
Publicado: (2009)

Pneumococcal Conjugate Vaccine Safety in Elderly Adults
por: Tseng, Hung Fu, et al.
Publicado: (2018)

Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review
por: Remschmidt, Cornelius, et al.
Publicado: (2016)

Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink
por: Hanson, Kayla E., et al.
Publicado: (2023)

Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination
por: Naleway, Allison L., et al.
Publicado: (2021)

Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012–13, 2013–14, and 2014–15
por: Donahue, James G., et al.
Publicado: (2019)

1162. Influenza Vaccination Among Pregnant People in the Vaccine Safety Datalink, 2016-17 through 2022-23 Influenza Seasons
por: Irving, Stephanie, et al.
Publicado: (2023)

2763. Uptake and Safety of Measles-Mumps-Rubella (MMR) Vaccine in Adolescents and Adults in the Vaccine Safety Datalink
por: Hanson, Kayla E, et al.
Publicado: (2019)

1163. Influenza Vaccination Coverage through December among Persons Ages Six Months and Older in the Vaccine Safety Datalink, 2017-18 through 2022-23 Influenza Seasons
por: Irving, Stephanie, et al.
Publicado: (2023)

Time interval of revaccination with 23-valent pneumococcal polysaccharide vaccine more than 5 years does not affect the immunogenicity and safety in the Japanese elderly
por: Kawakami, Kenji, et al.
Publicado: (2018)

Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink
por: Kenigsberg, Tat'Yana A., et al.
Publicado: (2023)

Safety of BCG vaccination and revaccination in healthcare workers
por: Villanueva, Paola, et al.
Publicado: (2023)

Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009–2011
por: Greene, Sharon K., et al.
Publicado: (2013)

Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems
por: Groom, Holly C., et al.
Publicado: (2022)

Prevention of Smallpox by Vaccination and Revaccination
por: Seal, S. C.
Publicado: (1945)

A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016
por: Irving, Stephanie A., et al.
Publicado: (2022)

Theory and strategy for Pneumococcal vaccines in the elderly
por: Namkoong, Ho, et al.
Publicado: (2015)

A Few Words on Vaccination and Revaccination
por: Atkinson, F. Page
Publicado: (1871)

Is It Right to Vaccinate or Revaccinate Pregnant Women?
Publicado: (1871)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
por: Shiramoto, Masanari, et al.
Publicado: (2015)

Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine Coadministered with a Quadrivalent Influenza Vaccine in Adults 50 Years and Older Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
por: Baxter, Roger, et al.
Publicado: (2015)

A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) revaccination coverage rate among elderly adults aged 65 and older and physician’s attitude
por: Nakamura, Atsushi, et al.
Publicado: (2020)

Small-Pox—Vaccination and Revaccination—False Ideas
Publicado: (1872)

Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly
por: Seo, Yu Bin, et al.
Publicado: (2017)

Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly
por: Rijkers, Ger T, et al.
Publicado: (2018)

Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea
por: Heo, Jung Yeon, et al.
Publicado: (2017)

Prevention of Smallpox by Vaccination and Revaccination: A Critical Study
por: Seal, S. C.
Publicado: (1945)

Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink
por: Hanson, Kayla E., et al.
Publicado: (2022)

Demand for pneumococcal vaccination under subsidy program for the elderly in Japan
por: Kondo, Masahide, et al.
Publicado: (2012)

Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly
por: Kuo, Chia-Sheng, et al.
Publicado: (2016)

On Revaccination
por: Braidwood, P. M.
Publicado: (1871)

Revaccination
Publicado: (1884)

On Revaccination
por: Russell, James B.
Publicado: (1871)

Revaccination
Publicado: (1858)

Revaccination
Publicado: (1872)

Revaccination
Publicado: (1871)

Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥45 Years in the United States, 2011–2012 to 2015–2016
por: Havers, Fiona P, et al.
Publicado: (2017)

Features of the Humoral Response to Infection, Vaccination, and Revaccination during COVID-19
por: Kombarova, S. Yu., et al.
Publicado: (2022)

Assessment of tetanus revaccination regimens in horses not vaccinated in the previous year
por: KINOSHITA, Yuta, et al.
Publicado: (2023)

Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink
por: Kenigsberg, Tat'Yana A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oi2v1vfqstktu4rdtdvg2lgnr7